Insider Transactions in Q2 2024 at Esperion Therapeutics, Inc. (ESPR)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 18
2024
|
Joanne M. Foody Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,285
-1.19%
|
$6,570
$2.87 P/Share
|
|
Jun 18
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,540
-1.51%
|
$5,080
$2.86 P/Share
|
|
May 23
2024
|
Jay Shepard Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+30.83%
|
-
|
|
May 23
2024
|
Stephen Rocamboli Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+38.81%
|
-
|
|
May 23
2024
|
Antonio M Jr Md D Phil Gotto Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+30.83%
|
-
|
|
May 23
2024
|
Alan Fuhrman Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+30.1%
|
-
|
|
May 23
2024
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+44.97%
|
-
|
|
May 23
2024
|
J Martin Carroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
23,000
+26.24%
|
-
|
|
May 17
2024
|
Eric Warren Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
192
-0.11%
|
$384
$2.48 P/Share
|